HIT Consultant February 9, 2022
Fred Pennic

What You Should Know:

Scopio Labs, provider of the world’s first full-field digital cell morphology solution, today announced a $50M investment for its end-to-end hardware and software platform for digitizing, quantifying and analyzing hematology and other digital cytology samples.

– The Series C round included OurCrowd, Aurum Ventures, Mizrahi-Tefahot Bank Invest and Ilex Medical, with the participation of strategic investors operating in the field and existing investors.

Scopio puts Peripheral Blood Smears front and center

Blood tests are among the most frequent medical procedures in the world, with billions conducted every year. For blood tests, a lab tech looking at the slide under a microscope can only see a tiny part of the sample at a time. A few...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Apps, Digital Health, Investments, Technology, Trends
Google announces new health-care AI updates for Search
Trauma can increase chatbots ‘anxiety:’ Study
EHRs and agentic AI: Balancing human and automated collaboration
AI, patient data firms aim to speed up drug development
Google launches tool to help patients compare health experiences

Share This Article